Jennifer Kim
Stock Analyst at Cantor Fitzgerald
(0)
# 3835
Out of 5,243 analysts
44
Total ratings
37.84%
Success rate
-1.47%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Insmed | Reiterates: Overweight | n/a | n/a | n/a | 6 | Jun 20, 2024 | |
Fortress Biotech | Reiterates: Overweight | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
EyePoint Pharmaceuti... | Reiterates: Overweight | n/a | n/a | n/a | 6 | Jun 20, 2024 | |
Belite Bio | Reiterates: Overweight | n/a | n/a | n/a | 3 | Jun 20, 2024 | |
Allakos | Reiterates: Neutral | n/a | n/a | n/a | 4 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 | n/a | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3 2 | 0.71 | 181.69% | 2 | Aug 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 14 | 3.25 | 330.77% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 33 | 4.72 | 599.15% | 2 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 5 | 2.31 | 94.81% | 2 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | n/a | n/a | 2 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 220 100 | 1.64 | 5997.56% | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 56 | n/a | n/a | 2 | Mar 17, 2022 |